Position in VCEL
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$3,665,578
-$468,009 QoQ
Shares Held
113,944
-0.7% QoQ
Ownership
0.223%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026KORNITZER CAPITAL MANAGEMENT INC /KS holds $45,330,914 across 13 Biotechnology names. VCEL ranks #5 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
60,342 | $12,047,280 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
113,499 | $7,335,440 | |
| 3 | TECH |
BIO-TECHNE Corp
|
130,270 | $6,807,910 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
|
175,870 | $4,143,497 | |
| 5 | VCEL |
Vericel Corp
This page
|
113,944 | $3,665,578 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
35,780 | $2,243,406 | |
| 7 | ZYME |
Zymeworks Inc.
|
88,800 | $2,223,552 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
29,105 | $2,185,494 |
All Filings in VCEL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,665,578 | 113,944 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $4,133,587 | 114,790 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $3,608,979 | 114,680 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $4,666,884 | 109,680 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $928,096 | 20,800 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $658,920 | 12,000 | Shares | Sole | 2025-01-31 | |
| No filing history on record for this holder in this stock. | ||||||